Aurinia Pharmaceuticals AUPH Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsAndOtherReceivablesNetCurrent.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's accounts receivable?
- Aurinia Pharmaceuticals (AUPH) reported accounts receivable of $49.18M in Q1 2026.
- How has Aurinia Pharmaceuticals's accounts receivable changed year-over-year?
- Aurinia Pharmaceuticals's accounts receivable increased by 21.9% year-over-year, from $40.35M to $49.18M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.